LXR as a novel antithrombotic target
- 26 May 2011
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 117 (21), 5751-5761
- https://doi.org/10.1182/blood-2010-09-306142
Abstract
Liver X receptors (LXRs) are transcription factors involved in the regulation of cholesterol homeostasis. LXR ligands have athero-protective properties independent of their effects on cholesterol metabolism. Platelets are involved in the initiation of atherosclerosis and despite being anucleate express nuclear receptors. We hypothesized that the athero-protective effects of LXR ligands could be in part mediated through platelets and therefore explored the potential role of LXR in platelets. Our results show that LXR-β is present in human platelets and the LXR ligands, GW3965 and T0901317, modulated nongenomically platelet aggregation stimulated by a range of agonists. GW3965 caused LXR to associate with signaling components proximal to the collagen receptor, GPVI, suggesting a potential mechanism of LXR action in platelets that leads to diminished platelet responses. Activation of platelets at sites of atherosclerotic lesions results in thrombosis preceding myocardial infarction and stroke. Using an in vivo model of thrombosis in mice, we show that GW3965 has antithrombotic effects, reducing the size and the stability of thrombi. The athero-protective effects of GW3965, together with its novel antiplatelet/thrombotic effects, indicate LXR as a potential target for prevention of athero-thrombotic disease.Keywords
This publication has 57 references indexed in Scilit:
- Non‐genomic effects of PPARγ ligands: inhibition of GPVI‐stimulated platelet activationJournal of Thrombosis and Haemostasis, 2010
- LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanismsAtherosclerosis, 2009
- The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivoBlood, 2009
- Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding modelJournal of Thrombosis and Haemostasis, 2009
- A dual role for integrin-linked kinase in platelets: regulating integrin function and α-granule secretionBlood, 2008
- Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoEJCI Insight, 2007
- Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human plateletsBlood, 2007
- Platelet PECAM-1 inhibits thrombus formation in vivoBlood, 2006
- Activation of Syk protein tyrosine kinase through interaction with integrin β cytoplasmic domainsCurrent Biology, 2001
- Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbαThe Journal of Experimental Medicine, 1998